Mr. Blake Brings More Than 20 Years of IT Leadership Experience in Technology Operations, Project Management, Systems Implementation, and Regulatory Compliance
JUNE 11, 2019—Durham, NC—BioAgilytix, a leading provider of contract bioanalytical testing services with specialization in large molecule bioanalysis, has announced the addition of Sean Blake to its leadership team as Chief Information Officer. In this role, Mr. Blake will lead the development, assessment, and execution of critical IT strategies across BioAgilytix’s international operations to support the company’s continued growth and position as a technologically-advanced bioanalytical services provider.
Mr. Blake brings more than 20 years of successful experience leading complex IT projects across various companies in the pharmaceutical and biotechnology industries. Prior to joining BioAgilytix, he was Director of Information Systems at BioCryst Pharmaceuticals, where he led the strategic planning, execution, and oversight of innovative policies and procedures for all Information Services department functions. His IT leadership experience spans technology operations, project management, systems implementation, and application support, and he holds extensive expertise in regulatory compliance including 21 CFR Part 11, Sarbanes-Oxley, FISMA, and FDA regulations.
“Sean’s extensive experience in our industry and in overseeing critical IT strategies across international, cross-functional, and multi-organizational teams makes him the ideal candidate for this position,” said Jim Datin, President and Chief Executive Officer of BioAgilytix. “As CIO, Sean will be in charge of overseeing our global IT function, which includes a myriad of responsibilities ranging from long-term IT strategy to security to networking and end user support. I have no doubt Sean will do well in his new position, and I know our leadership team looks forwarding to collaborating with him on new business strategies that implement emerging technologies to further progress the great growth we are experiencing here at BioAgilytix.”
“BioAgilytix’s reputation as a top-notch CRO for large molecule bioanalysis is unsurpassed, and I am very excited to become a part of their team,” said Mr. Blake. “I look forward to implementing technological systems that are innovative for the company and that will support and help accelerate BioAgilytix’s current growth trajectory.”
BioAgilytix is a leading bioanalytical testing laboratory specializing in large molecule bioanalysis. With laboratory locations in North Carolina’s Research Triangle area and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of biologics across a number of industries and disease states. BioAgilytix offers assay development, validation, and sample analysis under non-GLP, GLP, and GCP, as well as GMP quality control testing (i.e. product release testing, stability testing, etc.).
BioAgilytix’s team of highly experienced scientific and QA professionals ensures high quality science, data integrity, and regulatory compliance through all phases of clinical development, and is a trusted partner to many of the top global pharmaceutical and biotech companies. For more information, visit www.bioagilytix.com.